Christopher A. Viehbacher
President and Chief Executive OfficerBiogen
PharmaceuticalsView Profile →Chief Executive Officer · Viatris
Scott A. Smith is chief executive officer of Viatris. He became CEO in April 2023 after joining its board in December 2022, bringing biotechnology operating and commercial leadership from BioAtla and Celgene.
Last reviewed: Oct 21, 2026
Chief Executive Officer
Viatris
Last Reviewed: October 21, 2026
Scott A. Smith is chief executive officer of Viatris. He became CEO in April 2023 after joining its board in December 2022, bringing biotechnology operating and commercial leadership from BioAtla and Celgene.
Smith developed his pharmaceutical leadership experience at Celgene, where his roles included senior vice president and global head of immunology, president of Inflammation and Immunology, and president and chief operating officer. Those assignments combined therapeutic-area leadership with broader operating responsibility.
Before becoming Viatris CEO, he was president of BioAtla, a biotechnology company developing cancer therapies. His responsibilities included clinical development structure, strategic operating plans and business development. Viatris’ biography describes his work moving development programs from investigational applications toward late-stage studies.
Smith joined the Viatris board in December 2022 and became CEO in April 2023. He leads the company’s daily management and overall performance and works with the board on strategy. His company biography also records BioAtla board service and prior directorships at several biotechnology companies.